Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-102083·PERCEPTIVE ADVISORS LLC
Schedule 13D ownership disclosure
Solid Biosciences Inc
Common Stock, $0.001 par value per share · CUSIP: 83422E204
Event date: 2026-03-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLCReported CIK 0001224962
Shares: 11,969,079 · Class: 12.9%
- Joseph EdelmanReported CIK 0001164426
Shares: 11,969,079 · Class: 12.9%
- Perceptive Life Sciences Master Fund, Ltd.Reported CIK 0001249675
Shares: 11,895,972 · Class: 12.8%
- Perceptive Xontogeny Venture Fund, LPReported CIK 0001757940
Shares: 73,107 · Class: 0.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-102083
- Form type
- SCHEDULE 13D/A
- Filer
- PERCEPTIVE ADVISORS LLC
- CIK
- CIK 1224962
- Filed
- Mar 11, 2026
- Reporting period
- Mar 09, 2026
- Description
- Schedule 13D beneficial ownership